The efficacy of rituximab in pediatric patients with steroid-dependent or frequent relapsing nephrotic syndrome due to MCD or FSGS

BackgroundRituximab has been shown efficacy in reducing relapses among patients with steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS), primarily due to minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS). However, whether its efficacy differs between the...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yue Xi, Ying Liang, Zhi Chen, Lei Lei, Lan Mi, Xiaoyu Tian, Liuyu Sun, Qiang Sun, Nan Zhou
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2026-04-01
Edice:	Frontiers in Medicine
Témata:	children frequent relapsing nephrotic syndrome minimal change disease primary focal segmental glomerulosclerosis rituximab steroid-dependent nephrotic syndrome
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1763615/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!